top
Search terms
Results 1 - 10 of 10 - ordered by :
Eurointervention

Women (n=459; 23.3%) were older, more likely to have hypertension, lower creatinine clearance, and acute coronary syndrome (ACS), but had a lower severity of coronary artery disease (CAD). After ...

Date : 06/05/2016 Item size : 31487 bytes
Ehjournal

Permanent1 or transient2 intraluminal scaffolding of coronary arteries achieved by currently available stents effectively lowers the rate of acute vessel occlusion, persistent dissection, and ...

European Heart Journal, Editor's Viewpoint, Ronald K. Binder, Thomas F. Lüscher

Date : 21/05/2015
Ehjcvp

The aim of this review is to provide an overview of the evidence from randomized, clinical trials and epidemiological studies, with a focus on the optimal duration of dual antiplatelet therapy (DAPT) ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Pierre Sabouret, Sophie K. Rushton-Smith, Mathieu Kerneis, Johanne Silvain, Jean-Philippe Collet, Gilles Montalescot

Date : 01/07/2015
Ehjournal

Permanent1 or transient2 intraluminal scaffolding of coronary arteries achieved by currently available stents effectively lowers the rate of acute vessel occlusion, persistent dissection, and ...

European Heart Journal, Binder, Ronald K., Lüscher, Thomas F.

Date : 21/05/2015
Revistaespanola

INTRODUCTION In accordance with the policy on clinical practice guidelines of the Spanish Society of Cardiology (SEC),1 this article presents the novel, pertinent, and conflicting aspects of the 2017 ...

Revista Española de Cardiología

Date : 01/01/2018 Item size : 77046 bytes
Escardio

EMBARGO : 31 August 2015 at 14:30 BST “Coronary artery disease and acute coronary syndromes are the cause of death and disability in many patients,” said Dr Raban Jeger, interventional ...

Date : 31/08/2015
Escardio

The combination of ticagrelor and aspirin reduces ischaemic events compared with aspirin alone in patients with stable coronary artery disease and diabetes. Senior author Professor Deepak L. Bhatt ...

Date : 01/09/2019
Escardio

Senior author Professor Philippe Gabriel Steg of Hospital Bichat, Paris, France said: “Treatment with ticagrelor and aspirin also increased major bleeding relative to aspirin alone, but there ...

Date : 01/09/2019
Escardio

Professor Deepak L. Bhatt (Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA) describes the rationale for the study, which is the largest trial in type 2 ...

Date : 02/09/2019
Ehjournal

Dual antiplatelet therapy (DAPT, a combination of aspirin and a P2Y12 inhibitor), typically for up to 1 year, has been shown to be of benefit in patients undergoing percutaneous coronary intervention ...

European Heart Journal, Parker, William A.E., Storey, Robert F.

Date : 21/01/2016 Item size : 181230 bytes